Pilot safety study of liposomal prostaglandin (PGE1) in respiratory exacerbations in cystic fibrosis.

Abstract

BACKGROUND A pilot evaluation to assess the safety and possible benefits of TLC C-53, (prostaglandin E(1) associated with egg phosphatidylcholine liposomes) in acute respiratory exacerbations in children with cystic fibrosis (CF). METHODS Randomised, double-blind, placebo-controlled study in 20 P. aeruginosa colonised patients. All received intravenous… (More)

Topics

Cite this paper

@article{Taylor2002PilotSS, title={Pilot safety study of liposomal prostaglandin (PGE1) in respiratory exacerbations in cystic fibrosis.}, author={C. Taylor and Jean Mcgaw and Alan S Rigby and Dr E. J. Threlfall and Jacky Karmel}, journal={Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society}, year={2002}, volume={1 2}, pages={90-3} }